Document is current

Any future updates will be listed below

Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes

Crossref DOI link: https://doi.org/10.1186/s13287-015-0027-z

Published Online: 2015-03-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark